2007 B receptor blockers for heart failure guidelines(国外英文资料).docVIP

2007 B receptor blockers for heart failure guidelines(国外英文资料) The status of beta-blockers in chronic heart failure therapy - the latest guide to chronic heart failure in China Wearing ladies column Huazhong university of science and technology tongji medical school and medical school In recent years, in both basic research and clinical diagnosis and treatment of heart failure (hf) studies have made remarkable progress, a large number of evidence-based medical evidence has changed our understanding of some of the traditional hf, need us to change principle of diagnosis and treatment of heart failure. Therefore, Chinese scholars in the field of hf reference a large amount of literature and research, and foreign related guidelines, after much discussion and unremitting efforts, in chronic heart failure treatment guidelines of the Peoples Republic of China has revised and updated, and is carried out at the end of this month. New guide, beta-blockers application in the treatment of chronic heart failure has been fully set forth, its treatment status has been further consolidated, the economist professor invited famous experts of heart failure in China wear best column in this part for further reading. Be forthcoming in the latest edition of the Chinese guide therapy for chronic heart failure in heart failure drugs part again ranked beta-blockers I/class A drugs, emphasizes the important position to the management of heart failure: Low all chronic systolic heart failure, the New York heart association (NYHA) class II ~ III, in a stable condition and the phase B, patients with asymptomatic heart failure or NYHAI level [left ventricular ejection fraction (LVEF) 40%], beta blockers must be used, and the lifetime, unless there is contraindicated or cannot tolerate. Low NYHA class IV hf patients need to stay in a stable condition (4 days not intravenous drug use, has no fluid retention and constant weight), under the close guardianship by specialist guidance applications. The